May 2022Volume 175, Issue 5

ORIGINAL RESEARCH

1. Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured U.S. Adults

2. Risk for Acute Myocardial Infarction After Ophthalmologic Procedures

3. Risk for Shoulder Conditions After Vaccination: A Population-Based Study Using Real-World Data

4. Association Between Socioeconomic Disadvantage and Decline in Function, Cognition, and Mental Health After Critical Illness Among Older Adults

- A Cohort Study

5. Risks for Anaphylaxis With Intravenous Iron Formulations

- A Retrospective Cohort Study

6. Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring

- A Nationwide Cohort Study

7. The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine

- A Retrospective Cohort Study

8. Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge

- A Cross-Sectional Study

REVIEWS

9. Telehealth for Substance Use Disorders: A Rapid Review for the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Substance Use Disorders

10. Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points

RESEARCH AND REPORTING METHODS

11. A Reporting Tool for Adapted Guidelines in Health Care: The RIGHT-Ad@pt Checklist

CLINICAL GUIDELINES

12. The Management of Substance Use Disorders: Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline

IDEAS AND OPINIONS

13. The Ethics of Caring for Detained People on Hunger Strike

14. Integrating Quality Assurance and Quality Improvement With Guidelines: Systematic Stakeholder-Driven Development of an Extension of the Guidelines International Network–McMaster Guideline Development Checklist

15. Toward Unbiased Evaluation of Postacute Sequelae of SARS-CoV-2 Infection: Challenges and Solutions for the Long Haul Ahead

16. Prescribing Nirmatrelvir–Ritonavir: How to Recognize and Manage Drug–Drug Interactions

EDITORIALS

17. Preoperative Evaluation Can Delay Ophthalmologic Surgery Without Improving Outcomes

18. Health Equity and Critical Care Survivorship: Where Do We Go From Here?

19. Paternal Preconception Diabetes Drugs and Birth Defects in Offspring: A Call for More Conclusive Study

20. Shifting Focus to Evidence-Based Management of Substance Use Disorders

21. Building Connections Between Guidelines and Quality Improvement

22. Does Stopping Aspirin Differ Fundamentally From Not Starting Aspirin in the Primary Prevention of Cardiovascular Disease Among Older Adults?

ON BEING A DOCTOR

23. Matter Over Mind

LETTERS

24. Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial

- Observation: Brief Research Reports

25. Accuracy of Ultrasound Jugular Venous Pressure Height in Predicting Central Venous Congestion

- Comment

- Comment

- Response

26. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3)

- Update Alert

27. Update Alert 7: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings

- Update Alert

CORRECTIONS

28. Correction: Accuracy of Ultrasound Jugular Venous Pressure Height in Predicting Central Venous Congestion

AD LIBITUM

29. Version

30. Futility

IN THE CLINIC

31. Care of the Patient After Metabolic and Bariatric Surgery

ACP JOURNAL CLUB

32. In high-risk outpatients with COVID-19, remdesivir reduced COVID-19–related hospitalization or all-cause death at 28 d

33. In adults hospitalized with COVID-19, adding remdesivir to standard care did not reduce in-hospital mortality

34. In adults who had not had COVID-19, Novavax vaccine had 90% efficacy at ≥7 d after the second dose

35. In older adults having hip fracture surgery, regional vs. general anesthesia did not reduce postoperative delirium

36. In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes

37. In older persons at risk for dementia, a multidomain approach reduced stroke and transient ischemic attack

38. In overweight or obesity without diabetes, weekly semaglutide vs. daily liraglutide increased weight loss at 68 wk

39. In adults with overweight or obesity, adding weight-lowering drugs to lifestyle modification improves weight loss

40. Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons)

41. In CKD, the Kidney Failure Risk Equation predicted 2-y risk for ESKD better than eGFR alone

WEB EXCLUSIVES

42. Annals Graphic Medicine - Dr. Mom: Bedtime Hack

43. Annals Graphic Medicine - More Than Skin Deep

44. Annals for Educators - May 2022

45. Annals for Hospitalists Inpatient Notes - COVID-19, Hospital Medicine, and a Way Forward

SUMMARIES FOR PATIENTS

46. Summary for Patients: Risk for Heart Attack After Eye Procedures

47. Summary for Patients: Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring

48. Summary for Patients: PCR Testing Versus Rapid Antigen Testing at a Community Site During a COVID-19 Omicron Surge